CASI Pharmaceuticals, Inc. Contracts & Agreements

120 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Agreement and Plan of Merger, dated January 31, 2023 by and between CASI Pharmaceuticals, Inc. and CASI Pharmaceuticals Holdings, Inc
Merger Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2023
Equity Transfer Agreement between CASI Biopharmaceuticals (Wuxi) Co., Ltd. and Shenzhen Jiadao Gongcheng Equity Investment Fund (Limited Partnership) dated September 22, 2022
Investment Agreements
CASI Pharmaceuticals, Inc.
2022
Promissory Note issued by the Registrant to East West Bank, dated May 23, 2022
Note Agreements
CASI Pharmaceuticals, Inc.
2022
Sublicense Agreement between the Registrant and Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd, dated May 23, 2022
CASI Pharmaceuticals, Inc.
2022
Business Loan Agreement between the Registrant and East West Bank, dated May 23, 2022
Loan Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Commercial Security Agreement between the Registrant and East West Bank, dated May 23, 2022
Security Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Commercial Pledge Agreement between the Registrant and East West Bank, dated May 23, 2022
Pledge Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Amendment No. 1 to Employment Agreement
Employment Agreements
CASI Pharmaceuticals, Inc.
2021
First Amendment to Change in Control Agreement
Change of Control Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2021
Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
Form of CASI Pharmaceuticals Inc. Performance-Contingent 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2021
Form of CASI Pharmaceuticals Inc. 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2021
Form of CASI Pharmaceuticals Inc. Performance-Contingent 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2021
Form of CASI Pharmaceuticals Inc. 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2021
License and Development Agreement for CB-5339 by and between Cleave Therapeutics, Inc. and CASI Pharmaceuticals, Inc. dated March 5, 2021
License Agreements
CASI Pharmaceuticals, Inc.
2021
Description of Common Stock
Stock Agreements
CASI Pharmaceuticals, Inc.
2021
License Agreement, dated as of September 17, 2014, by and between CASI Pharmaceuticals, Inc. and Spectrum Pharmaceuticals, Inc
License Agreements
CASI Pharmaceuticals, Inc.
2021
License Agreement, dated as of September 17, 2014, by and between CASI Pharmaceuticals, Inc. and Spectrum Pharmaceuticals Cayman, L.P
License Agreements
CASI Pharmaceuticals, Inc.
2021
License Agreement, dated as of September 17, 2014, by and between CASI Pharmaceuticals, Inc. and Talon Therapeutics, Inc
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
Exhibit 1.1Underwriting Agreement, dated March 24, 2021, between CASI and Oppenheimer & Co. Inc
CASI Pharmaceuticals, Inc.
2021
Supplementary Agreement to the Exclusive License Agreement effective as of September 29, 2020
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Exhibit 1.1Underwriting Agreement dated July 22, 2020, between the Company and Oppenheimer & Co. Inc
CASI Pharmaceuticals, Inc.
2020
Description of Common Stock
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Contract for Assignment of the Right to the Use of the State-owned Construction Land (no. 3202842019CR0019) dated November 15, 2019
Assignment Agreements
CASI Pharmaceuticals, Inc.
2020
Exclusive License Agreement by and between CASI Pharmaceuticals, Inc. and Juventas Cell Therapy Ltd. effective June 15, 2019
License Agreements
CASI Pharmaceuticals, Inc.
2019
Investment Agreement in respect of Juventas Cell Therapy Ltd. executed June 15, 2019
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Open Market Sale AgreementSM by and between CASI Pharmaceuticals, Inc. and Jefferies LLC dated July 19, 2019
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2019
Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019
Stock Agreements
CASI Pharmaceuticals, Inc.
2019
Form of CASI Pharmaceuticals, Inc. Performance-Contingent 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2019
Form of CASI Pharmaceuticals, Inc. 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2019
Form of CASI Pharmaceuticals, Inc. Performance-Contingent 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2019
Form of CASI Pharmaceuticals, Inc. 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US)
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2019
Exclusive Distribution Agreement, effective as of March 5, 2019, by and among CASI Pharmaceuticals, Inc., China Resources Guokang Pharmaceuticals Co., Ltd. and CASI (Beijing)...
Distribution Agreements
CASI Pharmaceuticals, Inc.
2019
Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2019
Memorandum of Understanding, dated November 16, 2018, by and between Management Committee of Wuxi Hui-shan Economic Development Zone and CASI Pharmaceuticals, Inc
Development Agreements
CASI Pharmaceuticals, Inc.
2019
Investment Agreement, dated November 16, 2018, by and between Administrative Committee of Wuxi Huishan Economic Development Zone, Jiangsu Province and CASI Pharmaceuticals, Inc
Development Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Supplementary Agreement, dated November 16, 2018, by and between Administrative Committee of Wuxi Huishan Economic Development Zone, Jiangsu Province and CASI Pharmaceuticals, Inc
Development Agreements
CASI Pharmaceuticals, Inc.
2019
Shareholders Agreement, dated November 16, 2018, between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise (Limited Partnership)
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Lease Contract, by and between Wuxi Huishan New City Life Science & Technology Industry Development Co., Ltd. and CASI Pharmaceuticals, Inc
Lease Agreements
CASI Pharmaceuticals, Inc.
2019
Joint Venture Contract on Establishment of CASI (Wuxi) Pharmaceuticals Co. Ltd. by and between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise Limited...
Joint Venture Agreements
CASI Pharmaceuticals, Inc.
2019
Labor Contract, effective as of September 1, 2018, between CASI (Beijing) Pharmaceuticals, Inc. and Wei (Larry) Zhang
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Employment Agreement, effective as of September 28, 2018, between the Company and George Chi
Employment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2018
Form of Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2018
Form of Securities Purchase Agreement
Purchase Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2018
Asset Purchase Agreement, dated as of January 26, 2018, by and between CASI Pharmaceuticals, Inc. and Sandoz Inc
Purchase Agreements
CASI Pharmaceuticals, Inc.
2018
Form of Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
2018
Form of Securities Purchase Agreement
Purchase Agreements
CASI Pharmaceuticals, Inc.
2018
Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated February 23, 2018
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2018
Third Amendment to Secured Promissory Note, dated as of December 20, 2017, by and between the Company and Talon Therapeutics, Inc
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2017
Engagement Letter, dated as of October 12, 2017, by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC
CASI Pharmaceuticals, Inc.
2017
Form of Common Stock Purchase Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2017
Form of Wainwright Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2017
Form of Stock Purchase Agreement
Stock Agreements
CASI Pharmaceuticals, Inc.
2017
employmentagreement
CASI Pharmaceuticals, Inc.
2017
SECOND AMENDMENT TO SECURED PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
CASI Pharmaceuticals, Inc.
2015
FIRST AMENDMENT TO SECURED PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
2015
Confidential Materials omitted andfiled separately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT
Exchange Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
CA
2014
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT
Exchange Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2014
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT
Exchange Agreements
CASI Pharmaceuticals, Inc.
2014
CERTIFICATE OF DESIGNATIONS OF series A preferred stock Of CASIPHARMACEUTICALS, INC.
Stock Agreements
CASI Pharmaceuticals, Inc.
2014
SECURED PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
2014
INVESTMENT AGREEMENT
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2014
INVESTMENT AGREEMENT
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2014
employmentagreement
CASI Pharmaceuticals, Inc.
2013
ANNEX 1 INDEMNIFICATION AND CONTRIBUTION
Indemnification Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2013
FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc.
Warrant Agreements
CASI Pharmaceuticals, Inc.
2013
FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc.
Warrant Agreements
CASI Pharmaceuticals, Inc.
2013
SECURITIESPURCHASE AGREEMENT
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2013
EntreMed, Inc. / 9640Medical Center Drive / Rockville, MD 20850 Phone ###-###-#### / 240.864.2601fax
CASI Pharmaceuticals, Inc.
2012
CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2012
STANDBY EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreements
CASI Pharmaceuticals, Inc.
2011
Third Amendment to Lease Agreement
Lease Agreements
CASI Pharmaceuticals, Inc.
2011
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2011
SEPARATION AGREEMENT AND GENERAL RELEASE
Separation Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2011
THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIALTREATMENT REQUEST PURSUANT TO RULE 24b-2. REDACTEDMATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY...
Exchange Agreements
CASI Pharmaceuticals, Inc.
2010
FORMOF COMMONSTOCK PURCHASE WARRANT ENTREMED,INC.
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2010
SECURITIESPURCHASE AGREEMENT
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2010
WHARTON CAPITALMARKETS LLC
CASI Pharmaceuticals, Inc.
2010
STOCKPURCHASE AGREEMENT
CASI Pharmaceuticals, Inc.
2010
WHARTONCAPITAL MARKETS LLC
CASI Pharmaceuticals, Inc.
2010
STOCKPURCHASE AGREEMENT
CASI Pharmaceuticals, Inc.
Biotechnology
2010
Exhibit 1.1 WHARTON CAPITALMARKETS LLC
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2010
Exhibit10.1 STOCKPURCHASE AGREEMENT
CASI Pharmaceuticals, Inc.
2010
Amendment to Lease Agreement
Lease Agreements
CASI Pharmaceuticals, Inc.
2009
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2009
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
2009
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2008
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
2008
WARRANT TO PURCHASE 125,000 SHARES OF COMMON STOCK
Warrant Agreements
CASI Pharmaceuticals, Inc.
2007
WARRANT TO PURCHASE 62,500 SHARES OF COMMON STOCK
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2007
WARRANT TO PURCHASE 62,500 SHARES OF COMMON STOCK
Warrant Agreements
CASI Pharmaceuticals, Inc.
2007
LOAN AND SECURITY AGREEMENT
Loan Agreements
CASI Pharmaceuticals, Inc.
2007
PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
2007
PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2007
PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2007
CHANGE IN CONTROL AGREEMENT
Change of Control Agreements
CASI Pharmaceuticals, Inc.
2007
[ENTREMED LETTERHEAD]
CASI Pharmaceuticals, Inc.
2007
[ENTREMED LETTERHEAD]
CASI Pharmaceuticals, Inc.
2007
[ENTREMED LETTERHEAD]
CASI Pharmaceuticals, Inc.
2007
[ENTREMED LETTERHEAD]
CASI Pharmaceuticals, Inc.
2007
EntreMed, Inc. 2001 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2007
EntreMed, Inc. 2001 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2007
ENTREMED, INC. 2001 LONG-TERM INCENTIVE PLAN, AS AMENDED
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
2006
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2006
ELAN PHARMA INTERNATIONAL LIMITED
CASI Pharmaceuticals, Inc.
2006
RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Development Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2006
ENTREMED, INC.
CASI Pharmaceuticals, Inc.
2006
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
CASI Pharmaceuticals, Inc.
2006
AGREEMENT AND PLAN OF MERGER among: EntreMed, Inc. a Delaware corporation; E.M.K. Sub, Inc. a Delaware corporation; Miikana Therapeutics Inc. a Delaware corporation; and...
Merger Agreements
CASI Pharmaceuticals, Inc.
2005
License Agreement By and between EntreMed, Inc. and Celgene Corporation.
License Agreements
CASI Pharmaceuticals, Inc.
2005
[EntreMed Letterhead]
CASI Pharmaceuticals, Inc.
Biotechnology
2005
APPENDIX A
CASI Pharmaceuticals, Inc.
2005
EntreMed, Inc. 2001 Long-Term Incentive Plan Non-QUALIFIED Stock Option Grant Agreement
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2005
Optionee: OptioneeGrant: Grant_AmtNonqualified: NSO_AmtExercise Price: $Share_Price EntreMed, Inc. 2001 Long-Term Incentive Plan Non-QUALIFIED Stock Option Grant Agreement
Bonus & Incentive Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2005
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
2004
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2004
EMPLOYMENT AGREEMENT
Employment Agreements
CASI Pharmaceuticals, Inc.
2004